|
Initial reporter name: (b)(6).The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.Udi format updated with available product information per gudid.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
The reported event was inconclusive because this investigation did not result in any additional findings, and no sample was available for evaluation.(b)(6) was reviewed for this investigation.The reported event is addressed within the labeling as it state: warnings ¿ the purewick¿ flex female external catheter is designed for single-use only.Trying to wash, sanitize or reuse it may lead to risk of infection or illness.This may damage the product and materials.The product may not work and cause injury or illness.¿ to avoid potential skin injury, never push or rub the product against the skin during placement or removal.¿ do not block airflow to the product (e.G., blocking the vent hole, bedpan, barrier creams) ¿ do not insert the product into vagina, anus, or other body orifice.¿ stop use if an allergic reaction occurs.¿ after use, this product may be a potential biohazard.Dispose of in accordance with applicable local, state, and federal laws and regulations.¿ do not use on users with frequent episodes of stool incontinence without a fecal management system in place.¿ do not use on users with skin irritation or breakdown at the site.¿ use with caution on users who had recent surgery of the external female anatomy.¿ do not use on users with moderate/heavy menstruation who cannot use a tampon.Note: if skin irritation or breakdown is seen, do not use the product.Maintenance: - replace the product every 12 hours or if soiled with feces or blood.The baw is attached on the investigation overview element.(b)(4) was reviewed for this investigation.The risk documentation was addressed in step 3.04.This occurrence does not introduce a new hazard or harm.It represents a known failure mode that has been assessed in the product risk management file in accordance with applicable regulatory standards and internal procedures.The associated risks continue to be monitored as part of ongoing post-market activities in compliance with both regulatory requirements and local procedures.A dhr could not be performed since no lot number was provided.Udi format updated with available product information per gudid.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|